Kennet Brysting appointed General Manager, Gilead Canada

MISSISSAUGA, ON, Feb. 8, 2017 /CNW/ - Kennet Brysting has been appointed General Manager of Gilead Sciences Canada, Inc., assuming leadership of Gilead's sixth-largest market. The former General Manager of Gilead Nordics (Sweden, Norway, Denmark, Finland and Iceland), Kennet Brysting also joins Gilead's North America Commercial Senior Leadership Team.

Jim Meyers, Executive Vice President, Worldwide Commercial Operations, made the announcement, noting Mr. Brysting's selection followed a competitive interview process that heavily involved the Canadian Leadership Team and considered internal and external candidates from four different countries.

"Our top objective in the search process was to find the very best person to lead Gilead Canada at this time. That's not just in terms of leading Gilead Canada day to day, but to enable it to thrive and grow in the years ahead," Meyers said.

"It's a great honour to be selected to lead the Canadian business, and I am very excited to be moving to Canada," Brysting said. "I look forward to connecting and collaborating with the Canadian leadership team, our employees and our business partners and customers."

Mr. Brysting's appointment was effective January 9, 2017. He succeeds Ed Gudaitis, who left the company in October for another opportunity.

"My priority is a smooth transition, building on the past, strong leadership in Canada, collaborating with all of our stakeholders and developing a solid, strategic vision for the Canadian organization's future," Brysting said. "Gilead is committed more than ever to continuing to transform and simplify care for people with life-threatening illnesses and to ensure optimal access to the treatments they need." 

The multilingual Kennet Brysting has nearly 20 years of industry experience, including prior pharmaceutical industry General Manager experience, and more than four years as the General Manager for Gilead Nordics, which he grew to be one of Gilead's top-10 markets. He has an EMBA from Cranfield University, UK, and a Bachelor's Degree in Management Accounting from Copenhagen Business School.

"I'm confident Kennet brings to Gilead Canada an overall leadership philosophy that is consistent with what we aim for at Gilead: empower and hold accountable, in a manner that also inspires and motivates," Meyers said.

About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.  Gilead Sciences Canada, Inc. is the Canadian affiliate of Gilead Sciences, Inc., and was established in Mississauga, Ontario in 2005.

SOURCE Gilead Sciences, Inc.

Copyright 2017 Canada NewsWire

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Gilead Sciences Charts.